Trial · NCT01651949
Results by group68
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 68
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Geometric Mean Titers (GMTs) to the HPV Types Contained in the 9vHPV Vaccine | Heterosexual Males | Anti-HPV Type 6 (n=847, 708, 164) | 782.0 | 95% Confidence Interval 738.0 to 828.7 | milli Merck Units/mL |
| Geometric Mean Titers (GMTs) to the HPV Types Contained in the 9vHPV Vaccine | Females | Anti-HPV Type 6 (n=847, 708, 164) | 703.9 | 95% Confidence Interval 660.6 to 749.9 | milli Merck Units/mL |
| Geometric Mean Titers (GMTs) to the HPV Types Contained in the 9vHPV Vaccine | Men Who Have Sex With Men | Anti-HPV Type 6 (n=847, 708, 164) | 568.9 | 95% Confidence Interval 498.7 to 649.0 | milli Merck Units/mL |
| Geometric Mean Titers (GMTs) to the HPV Types Contained in the 9vHPV Vaccine | Heterosexual Males | Anti-HPV Type 11 (n=851, 712, 165) | 616.7 | 95% Confidence Interval 582.4 to 653.0 | milli Merck Units/mL |
| Geometric Mean Titers (GMTs) to the HPV Types Contained in the 9vHPV Vaccine | Females | Anti-HPV Type 11 (n=851, 712, 165) | 564.9 | 95% Confidence Interval 530.6 to 601.3 | milli Merck Units/mL |
| Geometric Mean Titers (GMTs) to the HPV Types Contained in the 9vHPV Vaccine | Men Who Have Sex With Men | Anti-HPV Type 11 (n=851, 712, 165) | 437.7 | 95% Confidence Interval 384.4 to 498.5 | milli Merck Units/mL |
| Geometric Mean Titers (GMTs) to the HPV Types Contained in the 9vHPV Vaccine | Heterosexual Males | Anti-HPV Type 16 (n=899, 781, 212) | 3346.0 | 95% Confidence Interval 3158.9 to 3544.1 | milli Merck Units/mL |
| Geometric Mean Titers (GMTs) to the HPV Types Contained in the 9vHPV Vaccine | Females | Anti-HPV Type 16 (n=899, 781, 212) | 2788.3 | 95% Confidence Interval 2621.4 to 2965.8 | milli Merck Units/mL |
| Geometric Mean Titers (GMTs) to the HPV Types Contained in the 9vHPV Vaccine | Men Who Have Sex With Men | Anti-HPV Type 16 (n=899, 781, 212) | 2294.0 | 95% Confidence Interval 2037.8 to 2582.5 | milli Merck Units/mL |
| Geometric Mean Titers (GMTs) to the HPV Types Contained in the 9vHPV Vaccine | Heterosexual Males | Anti-HPV Type 18 (n=906, 831, 220) | 808.2 | 95% Confidence Interval 754.9 to 865.4 | milli Merck Units/mL |
| Geometric Mean Titers (GMTs) to the HPV Types Contained in the 9vHPV Vaccine | Females | Anti-HPV Type 18 (n=906, 831, 220) | 679.8 | 95% Confidence Interval 633.1 to 730.1 | milli Merck Units/mL |
| Geometric Mean Titers (GMTs) to the HPV Types Contained in the 9vHPV Vaccine | Men Who Have Sex With Men | Anti-HPV Type 18 (n=906, 831, 220) | 608.1 | 95% Confidence Interval 529.4 to 698.5 | milli Merck Units/mL |
| Geometric Mean Titers (GMTs) to the HPV Types Contained in the 9vHPV Vaccine | Heterosexual Males | Anti-HPV Type 31 (n=908, 826, 227) | 708.5 | 95% Confidence Interval 662.7 to 757.6 | milli Merck Units/mL |
| Geometric Mean Titers (GMTs) to the HPV Types Contained in the 9vHPV Vaccine | Females | Anti-HPV Type 31 (n=908, 826, 227) | 570.1 | 95% Confidence Interval 531.5 to 611.5 | milli Merck Units/mL |
| Geometric Mean Titers (GMTs) to the HPV Types Contained in the 9vHPV Vaccine | Men Who Have Sex With Men | Anti-HPV Type 31 (n=908, 826, 227) | 420.7 | 95% Confidence Interval 368.0 to 480.9 | milli Merck Units/mL |
| Geometric Mean Titers (GMTs) to the HPV Types Contained in the 9vHPV Vaccine | Heterosexual Males | Anti-HPV Type 33 (n=901, 853, 230) | 384.8 | 95% Confidence Interval 362.5 to 408.4 | milli Merck Units/mL |
| Geometric Mean Titers (GMTs) to the HPV Types Contained in the 9vHPV Vaccine | Females | Anti-HPV Type 33 (n=901, 853, 230) | 322.0 | 95% Confidence Interval 302.9 to 342.3 | milli Merck Units/mL |
| Geometric Mean Titers (GMTs) to the HPV Types Contained in the 9vHPV Vaccine | Men Who Have Sex With Men | Anti-HPV Type 33 (n=901, 853, 230) | 252.3 | 95% Confidence Interval 224.2 to 283.8 | milli Merck Units/mL |
| Geometric Mean Titers (GMTs) to the HPV Types Contained in the 9vHPV Vaccine | Heterosexual Males | Anti-HPV Type 45 (n=909, 871, 232) | 235.6 | 95% Confidence Interval 219.0 to 253.6 | milli Merck Units/mL |
| Geometric Mean Titers (GMTs) to the HPV Types Contained in the 9vHPV Vaccine | Females | Anti-HPV Type 45 (n=909, 871, 232) | 185.7 | 95% Confidence Interval 172.3 to 200.2 | milli Merck Units/mL |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01651949/results